Pediatric Nephrology

, Volume 3, Issue 2, pp 228–228 | Cite as

Ask the expert

  • Richard J. Glassock


  1. 1.
    Border WA (1979) Immune complex detection in glomerular diseases Nephron 24: 105–113PubMedGoogle Scholar
  2. 2.
    Abrass CK, Hall CL, Border WA, Brown CA, Glassock RJ, Coggins CH (1980) Circulating immune complexes in adults with idiopathic nephrotic syndrome. Kidney Int 17: 545–553PubMedGoogle Scholar
  3. 3.
    Van Es LA (1988) Immunologic investigation of the nephrotic patient. In: Cameron S, Glassock RJ (eds) The nephrotic syndrome. Dekker, New York, pp 964–967Google Scholar
  4. 4.
    Schifferli J, Ng YC, Peters DK (1986) The role of complement and its receptor in the elimination of immune complexes. N Engl J Med 315:488–495PubMedGoogle Scholar
  5. 5.
    Levinsky RJ, Cameron JS, Soothill JF (1977) Serum immune complexes and disease activity in lupus nephritis. Lancet I: 564–567Google Scholar
  6. 6.
    Lloyd W, Schur PH (1981) Immune complexes, complement and anti-DNA in exacerbations of systemic lupus erythematosus. Medicine 60:208–217PubMedGoogle Scholar
  7. 7.
    Valentijn RM, Van Overhagen H, Hazevolt H, Hermans J, Cats A, Daha M, Van Es LA (1985) The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 28: 904–913PubMedGoogle Scholar
  8. 8.
    Bach JF, Jacob L, Feutren G, Tron F (1986) The questionable role of anti-DNA antibodies in the pathogenesis of systemic lupus erythematosus. Ann NY Acad Sci 474: 231–240Google Scholar
  9. 9.
    Abrass CK, Nies KM, Louie JS, Border WA, Glassock RJ (1980) Correlation and predictive accuracy of circulating immune complexes with disease actively in patients with systemic lupus erythomatosus. Arthritis Rheum 23: 273–282PubMedGoogle Scholar

Copyright information

© IPNA 1989

Authors and Affiliations

  • Richard J. Glassock
    • 1
  1. 1.Department of MedicineLAC Harbor-UCLA Medical CenterTorranceUSA

Personalised recommendations